Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9LJS

Structural insights into the polymerase catalyzed FAD-capping of hepatitis C viral RNA

Summary for 9LJS
Entry DOI10.2210/pdb9ljs/pdb
DescriptorRNA-directed RNA polymerase, RNA (5'-R(P*GP*GP*U)-3'), FLAVIN-ADENINE DINUCLEOTIDE, ... (6 entities in total)
Functional Keywordshepatitis c virus, rna polymerase complex, fad cap, viral protein
Biological sourceHepatitis C virus JFH-1
More
Total number of polymer chains2
Total formula weight64141.30
Authors
Wang, D.P.,Zhao, R.,Hu, W.S.,Li, H.N.,Cao, J.M.,Zhou, X.,Xiang, Y. (deposition date: 2025-01-15, release date: 2025-08-13, Last modification date: 2025-08-20)
Primary citationWang, D.P.,Zhao, R.,Hu, W.S.,Li, H.N.,Cao, J.M.,Zhou, X.,Xiang, Y.
Structural insights into polymerase-catalyzed FAD capping of hepatitis C virus RNA.
Nat Commun, 16:7298-7298, 2025
Cited by
PubMed Abstract: The RNA polymerase NS5B of HCV is capable of catalyzing the addition of flavin adenine dinucleotide (FAD) to its RNA as a 5' cap structure, aiding the virus in evading host immune responses. However, the exact mechanism underlying the 5'-FAD capping process of HCV RNA remains to be elucidated. Here, we determine crystal structures of the HCV NS5B de novo initiation, primed initiation and elongation complexes in presence of FAD. Structural analysis and comparisons show that residues M447 and Y448 of the β loop in the priming element (PE) of NS5B are the determinants for specific recognition of FAD. The adenine group of FAD is exclusively paired with the uracil base at the 3' end of the template RNA strand. At the initial elongation stage, the C-terminal linker (residues 530-570) of NS5B is involved in stabilizing the 5' FAD, which in turn induces sequential conformational changes of the bases in the product strand and creates a unique intermediate state of the RNA duplex, facilitating the translocation of the product strand. Our study offers novel insights for developments of new anti-HCV therapies.
PubMed: 40775214
DOI: 10.1038/s41467-025-62609-w
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.96 Å)
Structure validation

242500

건을2025-10-01부터공개중

PDB statisticsPDBj update infoContact PDBjnumon